The Novo Nordisk Foundation Center for Genomic Mechanisms of Disease aims to accelerate efforts to mine genetic data for insights into disease mechanisms and how human genetic variants affect a person's risk for common complex diseases. A key focus of the center will be understanding type 2 diabetes and obesity, and to map human gene regulation.

The center will be supported by a $47.5 million grant from the foundation, and it will be based at the Broad Institute. Grant funding is earmarked through 2026 with a possibility of refunding. Broad Institute associate member Kasper Lage, PhD, will direct the new center.

Harvard launches Pluto Biosciences collaboration platform
The Harvard Wyss Institute has launched Pluto Biosciences, a new startup offering a cloud-based collaboration platform for researchers that incorporates...

Broad Institute launches new center with $150M endowment
The Broad Institute of the Massachusetts Institute of Technology and Harvard University have announced the launch of a new research center intended to...

MIT researchers use natural language processing to analyze viral evolution
In a breakthrough that could guide the development of targeted vaccines, Massachusetts Institute of Technology (MIT) researchers used natural language...

Ideaya, Broad Institute partner on CRISPR synthetic lethality library
Ideaya Biosciences has entered into a target and biomarker discovery partnership with the Sellers Laboratory at the Broad Institute of Massachusetts Institute...

Ideaya and GSK partner on synthetic lethality programs
Ideaya Biosciences and GlaxoSmithKline (GSK) have formed a strategic partnership in the emerging oncology field of synthetic lethality.